In conclusion, this study suggests that treatment with melatonin may be beneficial in the prevention of experimental colitis in rats due to its antioxidant and anti-inflammatory properties, which were observed in the study in reducing MPO and MDA levels, pro-inflammatory cytokines (IL-1β and TNF-α), increasing GSH activity, and total antioxidant capacity. This evidence concerns the gene MPO and colitis.